glp-1 non responders Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Predicting responsiveness to GLP-1 pathway
Description
[DOI] [PubMed] [Google Scholar] 12.Kreymann B, Williams G, Ghatei MA, Bloom SR

PMID: 28507015

This has led to increased interest in whether medications like Wegovy might offer additional support for weight loss in this patient population, whilst raising important questions about safety and potential interactions with thyroid function

Engaging with GLP-1 users on platforms like TikTok and Instagram likely helps increase treatment awareness among younger adults, while also providing a positive example of what their own journey could look like
The Phase 2 trial , published in the New England Journal of Medicine, tested doses from 1 mg to 12 mg over 48 weeks